We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Teva Pharmaceutical Finance Netherlands III | TG:TFAC | Tradegate | Bond |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 74.48 | 73.591 | 74.479 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 0 | 07:44:17 |
| Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
|---|---|---|---|---|---|---|
| 06 Mar 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 05 Mar 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 04 Mar 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 03 Mar 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 28 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 27 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 26 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 25 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 24 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 21 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 20 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 19 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 18 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 17 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 14 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 13 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 12 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 11 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 10 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
| 07 Feb 2025 | 71.48 | 0.00 | 0.00% | 71.48 | 71.48 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
